RxDoctor Payments Data

Kelsie Court, MD

Family Medicine · Marshall, TXNPI 1982128716

Payments from drug & device makers

$1,862in general payments, 2019–2025

Across 89 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$380
  • AbbVie$203
  • Novo Nordisk$198
  • Bayer$153
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$143
  • Exact Sciences$102
  • plus $683 from 16 others

What the payments were for

  • Food & beverage$1,862100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,862 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$477
Medicare patients
25
Services billed
49

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide123$140,342
OzempicSemaglutide90$113,459
EliquisApixaban75$88,987
TrulicityDulaglutide71$83,215
JardianceEmpagliflozin37$64,715
Trelegy ElliptaFluticasone/Umeclidin/Vilanter82$60,455
FarxigaDapagliflozin Propanediol65$58,646
XifaxanRifaximin11$39,164
LinzessLinaclotide22$22,276
JanuviaSitagliptin Phosphate12$15,254
MyrbetriqMirabegron15$14,590
SymbicortBudesonide/Formoterol Fumarate17$7,002
Novolog FlexpenInsulin Aspart12$4,784
Albuterol Sulfate HfaAlbuterol Sulfate147$4,145
Gabapentin213$3,643

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$95$223,556194 claims
Novo NordiskOzempic$198$113,45990 claims
PfizerEliquis$380$88,98775 claims
AstraZenecaFarxiga, Symbicort$34$65,64882 claims
Boehringer IngelheimJardiance$76$64,71537 claims
GSKTrelegy Ellipta$44$60,45582 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$93$39,16411 claims
AbbVieLinzess$203$22,27622 claims
Sanofi-aventis U.S. LLCLantus$21$2,39216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Marshall

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →